Search results
-
Dr Daniel Hodson
... to characterise how new therapeutic agents that are entering trials for lymphoma may exert some of their effect though changes in ...
-
Professor Tim Eisen
... AstraZeneca, where I am currently responsible for oncology trials from first in man to Phase II. ...
-
Dr Elena Provenzano
... My primary interest is the translational aspect of clinical trials particularly in the neoadjuvant setting. Current trials include ARTemis, PARTNER, PRIMETIME and Neo-RT clinical trials in ...
-
Dr Finian Leeper
... properties and a close relative obatoclax is in clinical trials for multiple cancers. (b) synthesis of thiamin diphosphate (TPP) ...
-
Dr Gaia Schiavon
... biomarkers and study designs in ‘window of opportunity’ trials - Identification of newer imaging criteria for response assessment to ... RECIST’s limitations - Pharmacodynamics in clinical trials, disease linkage data to guide indication selection and targeted patient ...
-
Dr George Follows
... post, and I am developing a translational science / clinical trials interest. I am the clinical lead for CLL and lymphoma in Cambridge, and chair the Haematology Clinical Trials team. I am a committee member of the Cambridge Clinical Cancer Trials ...
-
Professor Grant Stewart
... a focus on developing and promoting surgery related clinical trials and translational research. Grant has a specific interest in optimising ... Stewart has developed a range of interlinked clinical trials and translational research which are all underpinned by clinical ...
-
Dr Helen Morris
... and collaborated on a number of randomised controlled trials and other well-designed studies in the field of cancer and genetics in a ...
-
Dr Helen Hatcher
... lead investigator in several multicentre and international trials. ...
-
Dr Kelly Holmes
... setting up and co-ordinating the work for clinical research trials with the aim of developing novel imaging techniques in patients with ...
-
Dr Ali Amin Al Olama
My research has focused on discovery of genetic risk factors of prostate cancer through genome-wide association studies and fine-mapping. I am a core member of an international consortium PRACTICAL (Prostate Cancer Association Group to Investigate...
-
Mr Arqum Anwar
Rotation Project: The project aims to investigate the cellular role(s) of a novel factor expected to be involved in DNA damage response. Specifically, the interactome of the protein will be explored using co-immunoprecipitation followed by mass...
-
Dr Andreas Bender
Previously affiliated with the Lead Discovery Informatics (LDI) group of Novartis in Cambridge/MA, I am now developing and applying cheminformatics techniques in the drug discovery field in my group with the University of Cambridge. Our expertise ranges...
-
Dr Alvis Brazma
High throughput (microarray, sequencing) data analysis. Data integration. Cell cycle. I am in charge of running and developing the transcriptomics data repository ArrayExpress.
-
Dr Alejandra Bruna
We aimed to study the effects of the TGF-beta pathway in breast cancer stem cell (BCSC) regulation. To define a role of the TGF-beta pathway in the regulation of human BCSCs, we have analyzed a panel of breast cancer cell lines that represent the...
-
Professor Antonis Antoniou
My main research interest is the development and application of statistical modelling techniques for addressing clinical questions, and the development of risk prediction tools which are used in clinical practice. ...
-
Dr Annalise Katz-Summercorn
Early detection in oesophageal adenocarcinoma
-
Dr Catherine Lindon
My lab studies cell division in human cells, with particular focus on regulation by ubiquitin-mediated proteolysis. We use time-lapse fluorescence imaging of live cells to measure proteolysis of substrates in real time, and to study the role of...
-
Professor Adrian Liston
We are focussed on understanding the biology of regulatory T cells within the tissues. How they migrate there, what controls their numbers and their functions, both immunological and tissue homeostatic in nature. Our approach is to identify key unknowns...
-
Dr Alison Dunning
Work in the Centre for Cancer Genetic Epidemiology "wet lab" involves running very high throughput SNP-chip genotyping and Next Generation Sequencing (NGS) studies. We search for genetic risk factors for both cancer susceptibility and treatment-response...
